Salvatore Carbone
Overview
Explore the profile of Salvatore Carbone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
172
Citations
4028
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dixon D, Salgado T, Robinson A, Carbone S, Wagner T, Hyder H, et al.
Mayo Clin Proc
. 2025 Mar;
PMID: 40057872
Objective: To determine the prescribing rates of sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) at cardiology, endocrinology, and primary care visits in a community health system....
2.
3.
Billingsley H, Carbone S, Driggin E, Kitzman D, Hummel S
JACC Adv
. 2025 Jan;
4(1):101465.
PMID: 39801812
Patients with heart failure with preserved ejection fraction (HFpEF) are burdened by multiple diet-sensitive comorbidities, including obesity and malnutrition. Despite this, a low percentage of patients with HFpEF have been...
4.
Kim J, Kenyon J, Billingsley H, Bohmke N, Ahmed S, Salmons H, et al.
PLoS One
. 2025 Jan;
19(12):e0315575.
PMID: 39774392
Introduction: The ActiGraph (AG) accelerometer is widely used to assess physical activity (PA) in heart failure (HF) patients. However, the validity of the AG in this population remains unexplored. Objective:...
5.
Mirzai S, Bancks M, Brinkley T, Carbone S, Tang W, Allison M, et al.
Clin Nutr
. 2024 Dec;
45:61-65.
PMID: 39740300
Background & Aims: Skeletal muscle (SM) health has significant prognostic value in geriatric and chronic disease populations, yet its assessment is frequently omitted due to challenges in evaluation. The creatinine-to-cystatin...
6.
Parlier-Ahmad A, Ochalek T, Bean M, Wolver S, Carbone S, Islam L, et al.
Subst Use Addctn J
. 2024 Dec;
:29767342241303220.
PMID: 39676245
Introduction: Medication for opioid use disorder (MOUD) is the most efficacious treatment for opioid use disorder (OUD). MOUD uptake and continuation may be impacted by health concerns, including weight gain,...
7.
Catalfamo V, Tutor A, Koos A, Vyas A, Lavie C, Carbone S
Curr Heart Fail Rep
. 2024 Nov;
22(1):1.
PMID: 39546123
Purpose Of Review: Since the turn of the millennium, obesity has been on the rise worldwide, and particularly so throughout the United States. Even more concerning is the rate at...
8.
Hartman H, Kim E, Carbone S, Miles C, Reilly M
Eur Heart J Cardiovasc Imaging
. 2024 Oct;
26(2):337-348.
PMID: 39397531
Aims: The purpose of this study was to characterize sex differences in the relationship between body composition and cardiac structure and function. In secondary analyses, we explored pathophysiologic mediators of...
9.
Kirkman D, Kidd J, Carbone S, Pontinha V, Tanriover B, Kumar D, et al.
J Am Soc Nephrol
. 2024 Aug;
35(11):1607-1609.
PMID: 39137041
No abstract available.
10.
Henson B, Bale-Neary C, Mecaskey R, Gbujie O, Zhan M, Rao K, et al.
J Cardiovasc Pharmacol
. 2024 Aug;
84(5):486-489.
PMID: 39115874
Patients undergoing anthracycline-based cancer treatments have an increased risk of heart failure or worsening preexisting heart failure as well as adverse metabolic outcomes such as malnutrition and cachexia. This retrospective...